Drug Profile
AZD 2098
Latest Information Update: 02 Nov 2005
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 02 Nov 2005 Discontinued - Preclinical for Asthma in United Kingdom (unspecified route)
- 09 Mar 2004 Preclinical trials in Asthma in United Kingdom (unspecified route)